These states are national leaders when it comes to driving 21st century forward. Today, we're looking at tech leaders across ...

If chivalry isn't already dead, it's certainly circling the drain. OpenAI CEO and tech billionaire Sam Altman recently ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Shares of Biogen Inc. BIIB shed 1.44% to $115.29 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and Dow ...

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...

Spotify appeared to be experiencing a widespread technical issues Wednesday morning — with tens of thousands of users ...

President Trump unveiled a wide-ranging executive order that aims to lower drug prices, boost transparency into fees charged ...

Mayoral candidate Scott Stringer is proposing a new zoning designation to block President Donald Trump from auctioning off federal buildings to luxury developers, the Daily News has ...

European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected the drug last summer. The infused treatment from Japanese drugmaker Eisai and ...